Atlas Trials

A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma

Clinical trial NCT00429949 · COMPLETED

Trial details

NCT number
NCT00429949
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed, Refractory or Plateau Phase Multiple Myeloma
Start date
2007-01-01
Primary completion
2008-01-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.